Global SNP Genotyping and Analysis Market Size to grow USD 69172 Million by 2030 | CAGR of 22%

Global SNP Genotyping and Analysis Market worth $69,172 million by 2030

According to a research report published by Spherical Insights & Consulting, the Global SNP Genotyping and Analysis Market size to grow from USD 11,553.0 million in 2021 to USD 69,172 million by 2030, at a Compound Annual Growth Rate (CAGR) of 22% during the forecast period.  The SNP genotyping and analysis market has grown due to the rising prevalence of fatal diseases such as cancer, diabetes and others. In addition, the growing demand for genetic analysis in animal and plant feedstock increasing the market growth.

Browse key industry insights spread across 213  pages with 114  market data tables and figures & charts from the report” Global SNP Genotyping and Analysis Market Size, Share, and COVID-19 Impact Analysis, By Technology (Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex, Sequemon MassArray Maldi-TOF, and Other), By Application (Diagnostic Research, Pharmacogenomics, Agricultural Biotechnology, Breeding and Animal Livestock), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2021 – 2030. “in detail along with the table of contents. https://www.sphericalinsights.com/reports/snp-genotyping-and-analysis-market

View a detailed Table of Content here–

The COVID-19 pandemic has made an adverse impact on credit portfolios. There has been an unprecedented rise in unemployment and disruption in economic activity, putting a strain on the solvency of customers and companies. Central banks have taken a proactive approach by injecting liquidity into the market by lowering interest rates and asset purchase programs. Managing and monitoring credit, market, liquidity, and operational risk across financial markets were hard enough with ongoing geopolitical tensions, international trade wars, and the occasional hurricanes and earthquakes. The current pandemic situation has forced chief risk officers and their teams to recalibrate old assumptions and models used to manage and monitor risk. COVID-19’s global impact has shown that interconnectedness plays an important role in international cooperation. As a result, many governments started rushing toward identifying, evaluating, and procuring reliable solutions powered by AI.

The SNP pyrosequencing segment accounts for the largest market size during the forecast period

Based on the technology, the global SNP genotyping and analysis market is categorized into Microarrays and GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex, Sequenom MassArray Maldi-TOF, and Other. The SNP pyrosequencing segment accounts for the largest market size during the forecast period. Based on the idea of sequencing by synthesis, pyrosequencing is another way to figure out the order of small pieces of DNA. When compared to the Sanger method, Pyrosequencing works better and takes less time. But this method can't always be used in the same ways as the traditional method.

The pharmacogenomics segment to hold a higher CAGR during the forecast period

Based on application, the SNP genotyping and analysis market is categorized into Diagnostic Research, Pharmacogenomics, Agricultural Biotechnology, Breeding and Animal Livestock. The pharmacogenomics segment to hold a higher CAGR during the forecast period. A big part of the pharmacogenomics market can be attributed to the growing industry for personalized medicine. For drug development purposes, SNPs in genetic materials are used a lot. Because of this, it is expected that the need for pharmacogenomics will increase, which will make the growth in the SNP Genotyping market.

North America is estimated to account for the highest market share in 2021.

The Global SNP genotyping and analysis market has been segmented into five major regions: Asia-Pacific, Europe, APAC, Latin America, and MEA. In the context of North America, the United States is expected to grow and change a lot. Because of the steadily rising number of chronic illnesses in the United States, it is likely that there will be more demand for genotyping tools and services. According to the most recent version of the article Chronic Diseases in America, which the National Center published for Chronic Disease Prevention and Health Promotion in January 2021, six out of ten adults in the United States have at least one chronic disease, and four out of ten adults have two or more chronic diseases. Genotyping techniques can be used to find and treat chronic diseases at an early stage. Asia-Pacific to hold a higher CAGR during the forecast period.

Major vendors in the global SNP genotyping and analysis market include Sequenom, Inc., Douglas Scientific LLC, PREMIER Biosoft, Sequenom Inc., Luminex Corp.,  Life Technologies Corp., Fluidigm, Illumina, Inc., Affymetrix, Inc.

Related Report:

Contact Us: https://www.sphericalinsights.com/contact-us